MAPT and Alzheimer disease: Neuroinflammation has been implicated as an early process in AD pathogenesis3, with transgenic mouse models showing that elevated cytokines in the central nervous system lead to increased Aβ and tau deposition, triggering further cytokine production and a positive feedback loop that amplifies AD pathology4,5.